Even vaccination must adapt to the constraints of geopolitics.
For the island of Taiwan, this means finding a way to supply doses of the precious serum that will not hit Beijing.
Read also:
Covid-19: fear of a rebound shakes Asia
On Sunday, Fosun Pharmaceutical, representative in China and several Southeast Asian countries of the German laboratory BioNTech, announced that it had signed an agreement with Taiwanese electronics giants Foxconn and Taiwan Semiconductor Manufacturing Co (TSMC) to sell them 10 million doses of vaccine.
Long set up as a model for its management of the health crisis, Taiwan has been facing a surge of the virus since the spring.
However, the archipelago is lagging behind in terms of vaccination.
Only 10% of the 23.5 million inhabitants received at least one dose.
Taipei claims to have tried for months to buy doses directly from BioNTech.
But he accuses China, which considers Taiwan as one of its provinces, of having blocked the negotiations.
What Beijing refutes, which continues to
This article is for subscribers only.
You have 39% left to discover.
To cultivate one's freedom is to cultivate one's curiosity.
Continue reading your article for € 1 the first month
I ENJOY IT
Already subscribed?
Log in
